Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
Cancer Cell International,
Abstract Background Immune checkpoint inhibitors are the most studied forms of immunotherapy for triple-negative breast cancer (T…